Fingerprint
Dive into the research topics of 'Ibrutinib inhibits pre-BCR+ B-cell acute lymphoblastic leukemia progression by targeting BTK and BLK'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Ibrutinib inhibits pre-BCR+ B-cell acute lymphoblastic leukemia progression by targeting BTK and BLK
Ekaterina Kim, Christian Hurtz, Stefan Koehrer, Zhiqiang Wang, Sriram Balasubramanian, Betty Y. Chang, Markus Müschen, R. Eric Davis, Jan A. Burger
Research output: Contribution to journal › Article › peer-review
57
Scopus
citations